Malignant catatonia
Abstract
The authors review catatonia, especially malignant catatonia, suggest a revised nomenclature, and establish a basis for furthering our understanding and treatment of this syndrome. After a brief historical review of catatonia, they review all available recent (1986-1991) English-language reports on malignant catatonia and summarize 5 cases of psychiatric malignant catatonia seen at their institution. Although much has been written about malignant catatonia "due to neuroleptics," malignant catatonia caused by other factors has received less attention, hindering our ability to recognize and treat non-neuroleptic- induced malignant catatonia. Catatonia, including malignant catatonia, occurs infrequently, but recognition and management are essential with a syndrome that can be life-threatening.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
